Danish Biotech Stock News

Despite an already strong run, ChemoMetec A/S ( CPH:CHEMM ) shares have been powering on, with a gain of 27% in the...

The Netcompany Group A/S ( CPH:NETC ) share price has done very well over the last month, posting an excellent gain of...

Brødrene A & O Johansen (CPSE:AOJ B) delivered 22.1% earnings growth this year, reversing a five-year trend of annual declines that averaged 4.5%. The company’s net profit margin ticked up to 3% from 2.8%. Its Price-To-Earnings Ratio at 14.6x sits below both peer and industry averages, and the stock’s price of DKK97.5 trades well under an estimated fair value of DKK370.81. Investors are watching this earnings turnaround and valuation story closely, as improved operational efficiency is...

Sydbank (CPSE:SYDB) reported a net profit margin of 34%, down from last year’s 42.9%. While the company has delivered average annual earnings growth of 23% over the past five years, the latest period saw earnings turn negative, hinting at some short-term challenges. Revenue is forecast to grow at 3.5% per year, which is slower than the Danish market average, while earnings are expected to track a similar growth rate, just above the broader market’s pace. The company’s high earnings quality...

H. Lundbeck (CPSE:HLUN B) is teaming up with OpenAI to integrate ChatGPT Enterprise across its organization. This move is intended to boost innovation and efficiency throughout the company’s operations. This partnership spotlights Lundbeck’s growing focus on technological transformation in brain health. See our latest analysis for H. Lundbeck. Momentum has been building for H. Lundbeck, as the stock’s 90-day share price return is an impressive 40.3%, while its one-year total shareholder...

Equinor recently announced its participation in Ørsted’s rights issue, marking a potential step toward strategic collaboration in offshore wind projects. This move highlights growing industry alliances as energy companies seek to accelerate the expansion of renewable energy infrastructure through shared expertise. We'll explore how Equinor's collaboration announcement may influence Ørsted’s investment outlook and broader renewable energy ambitions. These 11 companies survived and thrived...

With a price-to-earnings (or "P/E") ratio of 13.2x H. Lundbeck A/S ( CPH:HLUN B ) may be sending bullish signals at the...

Despite an already strong run, GreenMobility A/S ( CPH:GREENM ) shares have been powering on, with a gain of 25% in the...

There wouldn't be many who think Carlsberg A/S' ( CPH:CARL B ) price-to-earnings (or "P/E") ratio of 15.4x is worth a...

Genmab (CPSE:GMAB) shares have seen a modest dip over the past week, despite strong revenue and net income growth on an annual basis. Investors are likely weighing recent price movements along with improving fundamentals for the Danish biotech company. See our latest analysis for Genmab. Genmab’s share price has dropped 3.8% over the past week but remains firmly in positive territory for the year, building on its impressive 30% 90-day share price return. While recent volatility may reflect...

Per Aarsleff Holding (CPH:PAAL B) has had a great run on the share market with its stock up by a significant 14% over...

Key Insights The projected fair value for TORM is kr.225 based on 2 Stage Free Cash Flow to Equity TORM's kr.139 share...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

Embla Medical hf (CPSE:EMBLA) posted earnings forecast to grow at 14.51% per year, with revenue set to rise by 8.5% annually. Both figures are ahead of the Danish market’s expected growth. The company’s net profit margin edged up to 8.6% from 8.2% the year before. While the most recent year’s earnings growth came in at 11.7%, the broader five-year average sits at a robust 19.2% per year. Embla’s combination of faster-than-market growth and steadily improving profitability, coupled with a lack...

Recently released data indicates the Asia-Pacific mineral wool market is projected to grow at a 1.3% CAGR, reaching 15 million tons by 2035, with China accounting for nearly half of regional consumption and production, and Japan leading in market value. An especially large 37% increase in regional exports during 2024, driven primarily by China, highlights accelerating trade activity and solidifies the region’s growing importance for mineral wool producers like Rockwool. With rising...

Coloplast (CPSE:COLO B) has announced that interim CEO Lars Rasmussen will not stand for re-election to the Board at the upcoming annual general meeting in December. The search for a permanent CEO continues. See our latest analysis for Coloplast. Leadership shifts like these tend to put a spotlight on Coloplast’s next chapter, which investors are weighing against a challenging year. While recent days saw a modest 3.54% 7-day share price return, the 1-year total shareholder return has slumped...

At its Annual General Meeting held on 9 October 2025, ChemoMetec A/S approved a dividend distribution of DKK 7 per share of nominal value DKK 1. This move highlights the company's focus on returning capital to shareholders and may signal confidence in its ongoing financial stability. We'll explore how the approved dividend underscores ChemoMetec's shareholder priorities and affects its overall investment narrative. Find companies with promising cash flow potential yet trading below their...

In early October 2025, DSV A/S was named as a victim of a ransomware attack by a new hacking group called the Coinbase Cartel, which specifically targets logistics companies through data exfiltration and extortion tactics. This incident highlights the elevated and evolving cybersecurity risks facing global supply chain operators and the logistics industry as a whole. We will examine how these rising cybersecurity concerns, punctuated by the recent ransomware attack, may alter DSV's...

Recent reports have surfaced about DSV (CPSE:DSV) being targeted by a new hacking group that is focused on logistics companies. The ransomware claim highlights ongoing cybersecurity challenges for firms in the supply chain sector. See our latest analysis for DSV. DSV’s latest news comes after a challenging period for shareholders. While the company recently presented at the Xeneta Summit in Barcelona, its share price return year-to-date stands at -16.08%, and the past year’s total shareholder...

Key Insights Significant control over FLSmidth by retail investors implies that the general public has more power to...

GN Store Nord A/S ( CPH:GN ), might not be a large cap stock, but it received a lot of attention from a substantial...

If you're eyeing A.P. Møller - Mærsk and asking yourself whether now is the right time to buy, sell or just hang tight, you are certainly not alone. While many stocks have been doing a bit of a dance recently, Mærsk has shown its share of interesting moves that should catch the attention of any investor. In the short term, the share price has dipped, dropping 1.4% over the last week and 6.8% in the past month. But zoom out, and it is a very different story. The stock has climbed an impressive...

When you buy shares in a company, there is always a risk that the price drops to zero. On the other hand, if you find a...

The main aim of stock picking is to find the market-beating stocks. But even the best stock picker will only win with...